Arcosa, Inc.
ACA · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.71 | 0.12 | -0.10 | 1.04 |
| FCF Yield | 2.64% | 0.79% | -0.92% | 4.14% |
| EV / EBITDA | 34.89 | 37.53 | 48.03 | 59.10 |
| Quality | ||||
| ROIC | 2.16% | 1.80% | 1.02% | -0.73% |
| Gross Margin | 24.05% | 22.54% | 19.84% | 19.35% |
| Cash Conversion Ratio | 2.20 | 1.03 | -0.03 | -32.23 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.37% | 6.13% | 4.89% | 4.64% |
| Free Cash Flow Growth | 262.28% | 196.25% | -117.80% | 93.74% |
| Safety | ||||
| Net Debt / EBITDA | 8.00 | 10.06 | 14.23 | 14.74 |
| Interest Coverage | 4.14 | 3.33 | 1.97 | 1.22 |
| Efficiency | ||||
| Inventory Turnover | 1.44 | 0.00 | 1.39 | 1.49 |
| Cash Conversion Cycle | 69.24 | 11.35 | 75.37 | 67.85 |